These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34717623)

  • 21. Who benefits from government healthcare subsidies? An assessment of the equity of healthcare benefits distribution in China.
    Chen M; Fang G; Wang L; Wang Z; Zhao Y; Si L
    PLoS One; 2015; 10(3):e0119840. PubMed ID: 25781163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How China's new health reform influences village doctors' income structure: evidence from a qualitative study in six counties in China.
    Zhang S; Zhang W; Zhou H; Xu H; Qu Z; Guo M; Wang F; Zhong Y; Gu L; Liang X; Sa Z; Wang X; Tian D
    Hum Resour Health; 2015 May; 13():26. PubMed ID: 25940189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New evidence on financing equity in China's health care reform--a case study on Gansu province, China.
    Chen M; Chen W; Zhao Y
    BMC Health Serv Res; 2012 Dec; 12():466. PubMed ID: 23244513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China.
    Tang Y; Zhang X; Yang C; Yang L; Wang H; Zhang X
    BMC Health Serv Res; 2013 May; 13():183. PubMed ID: 23688333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who benefited from the New Rural Cooperative Medical System in China? A case study on Anhui Province.
    Wang L; Wang A; FitzGerald G; Si L; Jiang Q; Ye D
    BMC Health Serv Res; 2016 Jun; 16():195. PubMed ID: 27262341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of asymmetric medical insurance subsidy on hospitals competition under non-price regulation.
    Wang C; Nie PY
    Int J Equity Health; 2016 Nov; 15(1):184. PubMed ID: 27846902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unlocking SME growth: Analyzing the government subsidies' impact on financing in China.
    Sun W; Wang Z; Huang Y; Li Y
    PLoS One; 2024; 19(8):e0304589. PubMed ID: 39116049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Have lower-income groups benefited more from increased government health insurance subsidies? Benefit incidence analysis in Ningxia, China.
    Hu M; Mao W; Xu R; Chen W; Yip W
    Health Policy Plan; 2022 Nov; 37(10):1295-1306. PubMed ID: 35788317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.
    Zhang X; Wu Q; Liu G; Li Y; Gao L; Guo B; Fu W; Hao Y; Cui Y; Huang W; Coyte PC
    BMJ Open; 2014 Dec; 4(12):e006471. PubMed ID: 25534214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of village doctors in China: financial compensation and health system support.
    Hu D; Zhu W; Fu Y; Zhang M; Zhao Y; Hanson K; Martinez-Alvarez M; Liu X
    Int J Equity Health; 2017 Jul; 16(1):9. PubMed ID: 28666444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.
    Brixi H; Mu Y; Targa B; Hipgrave D
    Health Policy Plan; 2013 Dec; 28(8):809-24. PubMed ID: 23221008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catastrophic health expenditure in households with chronic disease patients: A pre-post comparison of the New Health Care Reform in Shaanxi Province, China.
    Xu Y; Ma J; Wu N; Fan X; Zhang T; Zhou Z; Gao J; Ren J; Chen G
    PLoS One; 2018; 13(3):e0194539. PubMed ID: 29547654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Persistence and Change in China's Healthcare Insurance Reform: Clues from Fiscal Subsidy Policies Made for Settling COVID-19 Patients' Medical Costs.
    Ma T; Guo B; Xu J
    Risk Manag Healthc Policy; 2022; 15():1129-1144. PubMed ID: 35637742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial accessibility of primary health care in China: A case study in Sichuan Province.
    Wang X; Yang H; Duan Z; Pan J
    Soc Sci Med; 2018 Jul; 209():14-24. PubMed ID: 29778934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.
    Guo Z; Guan X; Shi L
    BMC Health Serv Res; 2017 Nov; 17(1):723. PubMed ID: 29132361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomy of intergovernmental finance for essential public health services in China.
    Tan X; Wong C
    BMC Public Health; 2022 May; 22(1):914. PubMed ID: 35534861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.
    Jiang X; He P; Zhu D; Shi X; Meng Q
    Int J Equity Health; 2020 Dec; 19(1):219. PubMed ID: 33302978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The heterogeneous impacts of government on health system efficiency in China's new health reform, 2010-2019.
    Zhang J; Guo B; Fu X; Feng XL
    Int Health; 2024 May; 16(3):357-367. PubMed ID: 37624103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Did the poor gain from India's health policy interventions? Evidence from benefit-incidence analysis, 2004-2018.
    Selvaraj S; Karan AK; Mao W; Hasan H; Bharali I; Kumar P; Ogbuoji O; Chaudhuri C
    Int J Equity Health; 2021 Jul; 20(1):159. PubMed ID: 34246269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of health resource utilization efficiency in community health centers of Jiangsu Province, China.
    Xu X; Zhou L; Antwi HA; Chen X
    Hum Resour Health; 2018 Feb; 16(1):13. PubMed ID: 29463253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.